Person profile
Address
Conshohocken, Pennsylvania
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Nkarta, Inc.
28 Mar 24
4
CRISPR Therapeutics AG
27 Feb 24
4
eFFECTOR Therapeutics, Inc.
29 Nov 23
4
CRISPR Therapeutics AG
9 Jun 23
4
Nkarta, Inc.
9 Jun 23
4
Design Therapeutics, Inc.
2 Jun 23
4
Arcellx, Inc.
15 May 23
4
Design Therapeutics, Inc.
20 Dec 22
4
Turning Point Therapeutics, Inc.
17 Aug 22
4
Design Therapeutics, Inc.
16 Jun 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
27 Mar 24 | NKTX Nkarta | Common Stock | Buy | Acquire P | Yes | No | 10 | 451,659 | 4.52 mm | 451,659 |
27 Mar 24 | NKTX Nkarta | Common Stock | Buy | Acquire P | Yes | No | 10 | 1,548,341 | 15.48 mm | 1,548,341 |
27 Feb 24 | CRSP CRISPR Therapeutics | Common Shares | Grant | Acquire A | Yes | No | 71.5 | 769,196 | 55.00 mm | 769,196 |
27 Feb 24 | CRSP CRISPR Therapeutics | Common Shares | Grant | Acquire A | Yes | No | 71.5 | 216,578 | 15.49 mm | 216,578 |
27 Feb 24 | CRSP CRISPR Therapeutics | Common Shares | Grant | Acquire A | Yes | No | 71.5 | 63,177 | 4.52 mm | 63,177 |
27 Nov 23 | EFTR eFFECTOR Therapeutics | Common Stock | Sell | Dispose S | Yes | No | 0.6065 | 178,585 | 108.31 k | 1,821,415 |
27 Nov 23 | EFTR eFFECTOR Therapeutics | Common Stock | Sell | Dispose S | Yes | No | 0.6065 | 430,578 | 261.15 k | 4,391,536 |
8 Jun 23 | CRSP CRISPR Therapeutics | Stock Option Common Shares | Grant | Acquire A | No | No | 62.59 | 13,000 | 813.67 k | 13,000 |
7 Jun 23 | NKTX Nkarta | Stock Option Common Stock | Grant | Acquire A | No | No | 4.86 | 22,500 | 109.35 k | 22,500 |